Figure 4

Forest plots of primary efficacy and safety outcomes stratified by stroke type. The diamond indicates the estimated relative risk (RR) (95% confidence interval). The p-value showed on each figure is for heterogeneity test. Modified Rankin Scale (0–2) at 3 months: ischemic stroke, p for overall effect = 0.90, Q = 0.13; any stroke, p for overall effect = 0.82, Q = 13.07 (A). Mortality at 3 months: ischemic stroke, p for overall effect = 0.40, Q = 0.65; any stroke, p for overall effect = 0.10, Q = 3.47 (B).